The antidepressant drug imipramine was evaluated by means of a double blind study. Therapeutic results were assessed on the basis of a rating scale, psychological tests, and clinical course. Differences favoring the drug were found in some of the psychological tests, but in no clinical area were there significant differences between drug and placebo.Abstract Teaser